News
A new scientific breakthrough may soon offer hope for people affected by Alzheimer’s disease. A group of researchers in Spain ...
2monon MSN
To test their cutting-edge approach, the UW researchers focused on a well-studied enzyme called a serine hydrolase. The ...
Alzheimer’s disease is the most common cause of dementia, a condition that affects memory, thinking, and behavior. It slowly ...
Now, researchers are taking a different path. There’s growing evidence that neuroinflammation—inflammation in the brain—plays a major role in causing and worsening Alzheimer’s. The new drug works by ...
Medical Xpress on MSN17d
University of Barcelona team develops a new compound with therapeutic potential against Alzheimer’s diseaseThe new compound is an inhibitor of soluble epoxide hydrolase (sEH), an enzyme involved in the regulation of several physiological processes, including inflammation and pain response. “In the context ...
between SOC and oxidase/hydrolase activity was found in the alpine meadow but not in the swamp meadow) between the two meadows. This indicates that carbon input and enzyme characteristics jointly ...
The poly-ubiquitin chain is synthesized by a cascade reaction involving three enzymes, E1 (ubiquitin-activating ... UCH-L1 (ubiquitin carboxyl-terminal hydrolase) and α-synuclein, whose mutations ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results